Medical XpressIntensive Blood Pressure Control Protects the Heart—with No Added Kidney Failure Risk Detected

A meta-analysis of 27 randomized trials involving nearly 90,000 participants evaluated cardiovascular and kidney outcomes with intensive versus standard blood-pressure lowering, including outcomes according to chronic kidney disease status. Each 10-mmHg greater reduction in systolic pressure was associated with fewer major cardiovascular events and lower all-cause mortality, with similar cardiovascular benefit in participants with and without CKD. Intensive treatment did not increase kidney failure requiring dialysis or transplantation, although sustained eGFR declines occurred more often.

Clinical Considerations

• Each 10-mmHg reduction in systolic blood pressure was associated with a 15% reduction in major cardiovascular events, regardless of baseline CKD status.
• Absolute cardiovascular benefit was greater among participants with CKD: 4.2 versus 2.7 events prevented per 1,000 person-years without CKD.
• Intensive treatment did not increase kidney failure requiring dialysis or transplantation compared with standard blood-pressure lowering.
• Sustained eGFR declines of at least 30% and 40% occurred more frequently with intensive treatment, requiring distinction from kidney failure outcomes.
• Each 10-mmHg systolic-pressure reduction was associated with an 11% reduction in all-cause mortality across the trial population.
• The analysis addresses cardiovascular and kidney outcomes collectively, but individual blood-pressure targets still require interpretation within patient-specific clinical contexts.

Practice Applications

• Recognize that CKD did not attenuate the cardiovascular benefit associated with more intensive blood-pressure lowering in this meta-analysis.
• Interpret treatment-related eGFR declines separately from progression to kidney failure, particularly when evaluating renal safety.
• Monitor kidney function during intensive antihypertensive treatment rather than assuming an eGFR decline represents irreversible renal injury.
• Consider cardiovascular and renal outcomes together when individualizing blood-pressure targets in patients with CKD.